Mindfulness-Based Art Therapy for Cancer Patients

针对癌症患者的正念艺术治疗

• 批准号: 6361110
• 负责人: Daniel A Monti
• 金额: $ 19.63万
• 依托单位: THOMAS JEFFERSON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-09-24 至 2003-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6361110
• 关键词: age difference; alternative medicine; arts; behavioral /social science research tag; combination cancer therapy; coping; gender difference; group therapy; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; outcomes research; patient oriented research; psychological aspect of cancer; psychological stressor; quality of life; racial /ethnic difference; stress management

DESCRIPTION (provided by applicant): Psychosocial interventions, especially supportive-expressive group therapies, have been associated with significant improvements in health status, quality of life and coping behaviors, in patients with cancer. The purpose of the proposed pilot research study is to investigate a newly developed group therapy for cancer patients, MBAT. This proposed, randomized, controlled study follows a successful preliminary investigation of MBAT conducted at Thomas Jefferson University Hospital. MBAT integrates known benefits of art therapy, group therapy, and mindfulness-based stress reduction. Each of these fundamentally different modalities has documented usefulness in the treatment of cancer patients. The multi-modal approach is designed to enhance both the supportive and expressive aspects of the group experience. The study will be done with 96 patients who have a variety of cancer types. Participants will be matched for age and assigned randomly to either the MBAT experimental group or a non-intervention control group. Both groups will continue to receive their usual oncologic/medical care. The MBAT program consists of eight weekly meetings of two and one half-hours in length. At the end of the eight weeks, participants in the control group will be crossed over to the experimental intervention arm for an additional eight weeks. Participants will be assessed pre- and post-intervention on measures of health-related quality of life, psychological distress, and coping, using standardized outcome instruments (SF-36, SCL-90-R and COPE). Our long-term goal is to collect sufficient data to determine the overall efficacy of this promising intervention and to identify which patients are particularly likely to benefit from MBAT.

描述（由申请人提供）：心理心理干预措施，尤其是 支持表达的组疗法与大量相关 改善健康状况，生活质量和应对行为， 癌症患者。拟议的试点研究的目的是 研究新开发的针对癌症患者的小组疗法MBAT。这 提出的，随机的，对照研究遵循成功的初步 对托马斯·杰斐逊大学医院进行的MBAT的调查。 MBAT 整合已知的艺术疗法，小组疗法和基于正念的好处 压力减少。这些根本不同的方式都有 记录了治疗癌症患者的有用性。多模式 方法旨在增强支持性和表达性的方面 小组经验。该研究将与96名患者进行 多种癌症类型。参与者将与年龄相匹配并分配 随机与MBAT实验组或非干预控制 团体。这两个小组将继续接受他们通常的肿瘤/医疗服务。 MBAT计划包括八次和一个半小时的每周一次的会议 长度。在八周结束时，对照组的参与者将 越过实验干预臂又有八个 几周。将对参与者进行干预后的评估 与健康相关的生活质量，心理困扰和应对 标准化结果工具（SF-36，SCL-90-R和COPE）。我们的长期目标 是收集足够的数据以确定此的总体疗效 有希望的干预措施，并确定哪些患者特别可能 从MBAT中受益。